Mirena 20 Micrograms/Day (Levonorgestrel)

Adult use

This medication is inserted into the uterine cavity. It should be inserted within 7 days after the start of menstruation, and it can be replaced at any time during the menstrual cycle. If a miscarriage occurs within the first 3 months of pregnancy, it can be inserted immediately. For postpartum insertion, it should be done after waiting for the uterus to recover, 6 weeks after delivery. If recovery of the uterus is significantly delayed, consider waiting until 12 weeks after delivery. The insertion process requires knowledge of how to do an intrauterine insertion.

This medication should not be used if you are pregnant or suspect you might be pregnant. It should also not be used if there is an infection in the reproductive system, suspected cancer, abnormal uterine bleeding, or if the uterine structure is abnormal. Caution is needed if there is a history of pelvic inflammatory disease or thrombosis, or severe liver disease. Changes in bleeding patterns may occur while using this medication, and irregular bleeding or spotting is commonly seen initially. If pelvic pain, fever, or abnormal vaginal bleeding occurs, consult a physician immediately. This medication is an intrauterine device that can change position or expel partially after insertion, thus it needs regular position checks. If the threads are not felt or if there are suspicions of a positional abnormality, contact your healthcare provider. The risk of ectopic pregnancy may slightly increase, so if pregnancy is suspected, an evaluation must be conducted. This medication does not provide protection against infections; therefore, condom use is necessary for the prevention of sexually transmitted diseases. There may be potential interactions with certain medications, so inform your physician or pharmacist of any other medications you are taking. Regular check-ups and consultations are required during the use of this medication, and if abnormal symptoms appear, consult healthcare professionals immediately.

Serious side effects

Hives, angioedema, intrauterine infection (pelvic inflammatory disease and endometritis), cervicitis, uterine perforation, sepsis (including streptococcal A sepsis), ectopic pregnancy, anemia, jaundice, severe headache, migraine with unilateral vision loss, symptoms indicative of transient ischemic attack, severe headache, sudden vision problems, severe hypertension, breast cancer, stroke, myocardial infarction, severe arterial disease

Mild side effects

• Continuous bleeding
• irregular bleeding
• amenorrhea
• infrequent bleeding
• feelings of depression/depression
• irritability
• decreased libido
• mood changes
• headache
• migraine

This medication should be stored unopened in a place that is not humid and does not have direct sunlight. Additionally, it is safe to keep the storage temperature below 30 degrees. Proper storage will help maintain the effectiveness of the medication.

Appearance

An intrauterine system with a white or almost white drug storage device covered in an opaque membrane attached to the vertical part of the T-shaped body. There is a ring at the end of the vertical part of the white T-shaped body, and at the other end, there are two

Package unit

1 set